About two decades after first devising a new kind of vaccine, researchers are unlocking why it stops and ultimately clears the monkey form of HIV in about half of nonhuman primates – and why it’s a promising candidate to stop HIV in people. Recent scientific papers describe how unusual biological mechanisms that make the cytomegalovirus vaccine platform work.